tag:blogger.com,1999:blog-10381465.post2409824610786638983..comments2007-03-10T09:45:49.722-08:00Wesley J. Smithhttp://www.blogger.com/profile/00087063614354714652wjs@wesleyjsmith.comBlogger2125tag:blogger.com,1999:blog-10381465.post-20729783931548082572007-03-10T09:45:00.000-08:002007-03-10T09:45:00.000-08:00There are ongoing adult stem cell studies to treat human heart transplant-requiring patients in progress. Annecdotal reports about these studies have indicated that people who required heart transplants before receiving the ASC infusion, did not afterwards. This hasn't yet been peer reviewed, so it remains annecdotal--just like this ESCR story. If it is true, however, the ESCR in this arena might be rendered superfluous--at least as to therapeutic use.Wesley J. Smithhttp://www.blogger.com/profile/00087063614354714652noreply@blogger.comtag:blogger.com,1999:blog-10381465.post-70073346984700329082007-03-10T09:24:00.000-08:002007-03-10T09:24:00.000-08:00Wonder if it can be replicated with ASC? Of course, it one thing to make a small part of an organ but how to integrate it? It would seem that being able to add new tissue to a failing liver or pancreas would have great applications, but would adding new heart muscle cells actually "pump it up" - the pass/fail test of course having ultimate consequenceRobert Bhttp://www.blogger.com/profile/10573748023906738852noreply@blogger.com